ASM International (ENXTAM:ASM) Q3 Earnings Raise Growth Questions After EPS Fell

Simply Wall St · 1d ago

ASM International walked into Q3 2026 earnings with a hot reputation and a cooler tape, after the stock slipped about 8.9% over the past month yet edged higher over the past week. The fresh numbers landed with a jolt. Revenue reached €1,159.4m and basic earnings per share came in at €6.30, both solid figures for a capital equipment supplier in a still choppy semiconductor cycle. The question for today is simple. The price already embeds high expectations, so the real tension is whether this quarter justifies that premium or the emotion ran ahead of the data.

Love ASM International’s solid Q3 headline numbers but uneasy about paying up for a stock where expectations already look rich? Check the 195 high quality undervalued stocks.

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs Q3 2025): €1,159.4m vs. €800.0m (up about 45.0%)
  • Net Income (Excl. Extra Items, Q3 2026 vs Q3 2025): €308.1m vs. €384.2m (down about 19.8%)
  • Basic EPS (Q3 2026 vs Q3 2025): €6.30 vs. €7.86 (down about 19.8%)
  • Trailing 12-Month Net Profit Margin (latest vs. prior year): 26.8% vs. 23.9% (higher margin level year on year)

Earnings for ASM International are one thing, but investors who care about what they are paying for the business usually pay closer attention to cash that actually comes through the door. If you look only at ASM International's cash flows and the implied future stream, the stock could be a clear 26% overvalued.

ENXTAM:ASM Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026
ENXTAM:ASM Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026

Evaluating Whether ASM’s Growth Engines Are Firing

The bullish pitch on ASM International hinges on new platforms and adjacencies turning from promise into measurable traction.

"The main thing that has to go right is that ASM International converts its expanded opportunity in DRAM transitions, adjacent process steps such as PECVD and CMP, and advanced packaging into sustained orders while managing China related uncertainty."

Record Q3 2026 revenue of €1,159.4m and a higher trailing net margin of 26.8% indicate that the broader toolkit is starting to contribute more meaningfully. Management has already brought the old 2030 revenue ambition forward to 2027. This reflects how the addressable opportunity in PECVD, CMP and packaging is translating into real business, rather than remaining solely a pipeline story.

The price and this Narrative do not agree. → Uncover what this Narrative says ASM International is actually worth.

ASM Bear Case: Execution Risks Meet Mixed Signals

Bearish investors argue that ASM International’s internal execution is the real swing factor for AI driven growth, not macro headlines.

"Supply chain stress, with allocations and dual sourcing now described as critical to meet accelerated delivery requests, creates a structural risk that expedited sourcing, overtime and redesign work erode the company’s raised long term gross margin target range and limit operating leverage even if reported revenue meets current expectations."

Q3 tells a split story. Record €1,159.4m revenue and a higher trailing 26.8% net margin show no obvious margin crack, yet basic EPS fell 19.8% year on year. That drop hints at cost pressure and weaker operational gearing, which means the concern about strained operating leverage is not fully cleared by this quarter’s print.

Hunt For Mispriced Growth Stories

ASM International reported strong revenue with more complex earnings signals for investors to examine. The real opportunity sits in finding stocks that could be undervalued before the market corrects them.

  • Company 1 - 23% below our estimate - focus on pushing robotic surgical platforms and smart care services into higher acuity procedures.
  • Company 2 - 31% below our estimate - expand fee based funds that channel capital into renewable assets and tax efficient investment products.
  • Company 3 - 21% below our estimate - restructure and reprice ventilation systems while shifting production capacity toward regions with stronger demand momentum.

That is three of the list. See every one of the 195 undervalued companies on it →